Annals of Internal Medicine· 2016Q1· Guideline
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians
- 1,950citations
- Q1SCImago
- 2016year
Short summary
The American College of Physicians (ACP) recommends cognitive behavioral therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia disorder in adults, supported by moderate-quality evidence.
AI-generated from the title and abstract; the full text is not read.
Key points
- Cognitive behavioral therapy for insomnia (CBT-I) is the recommended initial treatment for chronic insomnia disorder in adults.
- The recommendation for CBT-I is based on moderate-quality evidence.
- For patients unresponsive to CBT-I, a shared decision-making process for short-term medication use is advised.
- The evidence for adding medication after CBT-I is of low quality, with a weak recommendation.
AI-generated from the title and abstract; the full text is not read.
Abstract
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of chronic insomnia disorder in adults. METHODS: This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015. Evaluated outcomes included global outcomes assessed by questionnaires, patient-reported sleep outcomes, and harms. The target audience for this guideline includes all clinicians, and the target patient population includes adults with chronic insomnia disorder. This guideline grades the evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. RECOMMENDATION 1: ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder. (Grade: strong recommendation, moderate-quality evidence). RECOMMENDATION 2: ACP recommends that clinicians use a shared decision-making approach, including a discussion of the benefits, harms, and costs of short-term use of medications, to decide whether to add pharmacological therapy in adults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone was unsuccessful. (Grade: weak recommendation, low-quality evidence).
The authors' abstract, as published at the source. Annals of Internal Medicine, 2016 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Experimental and Cognitive Psychology
Experimental and Cognitive PsychologyPsychology